Aiai Gao

Epigenetic heterogeneity in cancer

J. Herman, Min Guo, M. Guo, 2019, Biomarker Research.

Epigenetic heterogeneity in cancer

J. Herman, M. Guo, Yaojun Peng, 2019, Biomarker Research.

Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer

J. Herman, Lirong Zhang, Lidong Wang, 2021, Cancer science.

Epigenetic based synthetic lethal strategies in human cancers

M. Guo, Aiai Gao, 2020, Biomarker research.

Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma

Yun Liu, Pinli Yue, M. Guo, 2020, Clinical Epigenetics.

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer.

Meiying Zhang, Honghui Lv, Aiai Gao, 2024, Frontiers of medicine.

Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling

Meiying Zhang, Aiai Gao, Mingzhou Guo, 2024, Epigenomics.

Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer

Meiying Zhang, Aiai Gao, Mingzhou Guo, 2024, Clinical and translational gastroenterology.